Literature DB >> 30094609

Osteoporosis and osteopenia in the distal forearm predict all-cause mortality independent of grip strength: 22-year follow-up in the population-based Tromsø Study.

A V Hauger1, A Bergland2, K Holvik3, A Ståhle4,5, N Emaus6, B H Strand3,7,8.   

Abstract

Low bone mineral density (BMD) gives an increased risk of fractures, which can lead to premature death. Can BMD of the wrist predict mortality? BMD consistent with osteopenia and osteoporosis gave a significantly increased risk of death for both men and women in a general population in Tromsø, Norway.
INTRODUCTION: To investigate if bone mineral density (BMD) levels of the distal forearm, consistent with osteopenia and osteoporosis, can predict mortality and if grip strength is an effect modifier.
METHODS: The study population constituted 6565 participants aged 50-79 years at baseline in the Tromsø Study wave 4 conducted in 1994-1995. Forearm BMD measured by SXA was categorized as "normal," "osteopenia," or "osteoporosis" following WHO's definition. Cox regression with all-cause mortality as the outcome over 22 years of follow-up was performed for men and women separately, adjusting for health-related factors, as well as BMD by grip strength interaction. A secondary analysis with a 15-year follow-up also adjusted for hip fractures and osteoporotic fractures.
RESULTS: During follow-up, 3176 of participants died (47%). Those categorized as osteoporotic had higher mortality hazard ratio (HR) compared to those with normal BMD; men HR = 1.37 (95% confidence interval (CI) 1.19, 1.58) and women HR = 1.32 (1.14, 1.53) were adjusted for age, body mass index, physical activity, smoking habits, education, health status, chronic diseases, and grip strength. Corresponding HRs for osteopenia were men HR = 1.13 (1.00, 1.27) and women HR = 1.17 (1.01, 1.35). Further adjustments for fractures did only marginally attenuate the results, and HRs were still significant. There was no grip strength by BMD interaction.
CONCLUSION: Men and women with low distal forearm BMD values, consistent with osteoporosis or osteopenia, had an increased mortality compared to normal BMD participants. High grip strength did not modify this association, and the association remained after adjustment for a range of health-related factors.

Entities:  

Keywords:  Bone mineral density; Grip strength; Hip fracture; Mortality; Osteopenia; Osteoporosis

Mesh:

Year:  2018        PMID: 30094609     DOI: 10.1007/s00198-018-4653-z

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  1 in total

1.  Impact of smoking, diabetes and hypertension on survival in the elderly: the Dubbo Study.

Authors:  Peter A Frith
Journal:  Med J Aust       Date:  2005-05-02       Impact factor: 7.738

  1 in total
  4 in total

1.  Distinct biomarkers for different bones in osteoporosis with rheumatoid arthritis.

Authors:  T Tomizawa; H Ito; K Murata; M Hashimoto; M Tanaka; K Murakami; K Nishitani; M Azukizawa; A Okahata; K Doi; M Saito; M Furu; M Hamaguchi; T Mimori; S Matsuda
Journal:  Arthritis Res Ther       Date:  2019-07-15       Impact factor: 5.156

2.  Low Grip Strength and Muscle Mass Increase the Prevalence of Osteopenia and Osteoporosis in Elderly Women.

Authors:  Kyujin Lee; Ji Young Lee; Yong Hwan Kim
Journal:  Healthcare (Basel)       Date:  2021-04-16

3.  Bone mineral density and risk of cardiovascular disease in men and women: the HUNT study.

Authors:  Laxmi Bhatta; Aivaras Cepelis; Sigrid A Vikjord; Vegard Malmo; Lars E Laugsand; Håvard Dalen; Arnulf Langhammer; Imre Janszky; Linn B Strand; Ben M Brumpton
Journal:  Eur J Epidemiol       Date:  2021-09-13       Impact factor: 8.082

4.  Association Between Diet, Physical Activity and Body Mass Index, Fat Mass Index and Bone Mineral Density of Soldiers of the Polish Air Cavalry Units.

Authors:  Anna Anyżewska; Roman Łakomy; Tomasz Lepionka; Ewa Szarska; Ewelina Maculewicz; Andrzej Tomczak; Jerzy Bertrandt
Journal:  Nutrients       Date:  2020-01-17       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.